Ind-Swift Laboratories Limited Share Price and Company Fundamentals
Last traded: Today at 4:04 AM
Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, alcohol abstinence, and antineoplastic, as well as various products for ADHD symptoms. It provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, aripiprazole, atorvastatin calcium, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, Clarithromycin, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nitazoxanide, quetiapine, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide. The company also offers early and late phase drug development, process research and development, contract and API manufacturing, and custom chemicals and synthesis; and analytical development, regulatory support, chemistry, impurity profiling, isolation, discovery, identification and characterization, and project management services. It also exports its products. Ind-Swift Laboratories Limited was founded in 1995 and is based in Manimajra, India.
Key Metrics
PE ratio
-
PB ratio
0.60
Dividend yield
0.00%
Beta
-0.31
Market cap
-
Enterprise value
-
Company profile
| Industry / Sector | Drug Manufacturers—Specialty & Generic / Healthcare |
|---|---|
| Website | https://www.indswiftlabs.com |
| Mailing address | Shivalik Enclave SCO 850 NAC Manimajra 160101 India |
| Phone / Fax | 91 17 2273 0503 / 91 17 2273 0504 |
Dividends
Dividend yield
0.00%
Dividend amount
₹0.00
Payout ratio
0.00%
Ind-Swift Laboratories Limited paid ₹0.00 dividend and the ex-dividend date was 20 Sept 2011.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.INDSWFTLAB dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
INDSWFTLAB's forward dividend amount is ₹ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of Jul 2022, following are the company executives and directors listed on Ind-Swift Laboratories Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Navarattan Munjal | Chairman & MD | 69 | 32.74M |
| Mr. Himanshu Jain | Joint MD & Whole Time Director | 39 | 26.19M |
| Mr. Rishav Mehta | Exec. Director | 30 | 13.1M |
| Mr. Sahil Munjal | Pres of Operations & Special Assignments & Exec. Director | 41 | 14.91M |
| Mr. Sunil Deshmukh | Chief Exec. Officer | ||
| Mr. Gagan Aggarwal | Chief Financial Officer | ||
| Mr. Lovekesh Mahajan | Chief Accounts Officer | ||
| Mr. Pardeep Verma | Assistant VP of Corp. Affairs, Compliance Officer & Company Sec. | ||
| Mr. Atul Chaubey | Group Head of HR | ||
| Mr. Vikas Narendra | Pres of US Operations |
Profitability and management effectiveness
Profit margin
-0.20%
Operating margin
9.99%
Return on assets
3.73%
Return on equity
-0.36%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Ind-Swift Laboratories Limited is and its enterprise value is .
Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Frequently Asked Questions
1. What is Ind-Swift Laboratories Limited's Stock Symbol?
Ind-Swift Laboratories Limited trades on NSE under the ticker symbol "INDSWFTLAB".
2. What is Ind-Swift Laboratories Limited's stock price today?
One share of INDSWFTLAB stock can currently be purchased for approximately ₹60.8.
3. How can I contact Ind-Swift Laboratories Limited?
Ind-Swift Laboratories Limited's mailing address is Shivalik Enclave SCO 850 NAC Manimajra 160101 India. The company can be reached via phone at 91 17 2273 0503.
4. What is Ind-Swift Laboratories Limited's official website?
The official website of Ind-Swift Laboratories Limited is https://www.indswiftlabs.com.